Abstract: A bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose of "Belclene 350" and a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one ("Kathon 886F"). The active biocidal component of the "Belclene 350" product is tri n-butyl tetradecyl phosphonium chloride. The method comprises administering between about 0.1 to about 200 parts of this combined treatment (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.
Type:
Grant
Filed:
August 13, 1990
Date of Patent:
November 5, 1991
Assignee:
Betz Laboratories, Inc.
Inventors:
Wilson K. Whitekettle, Deborah K. Donofrio
Abstract: A bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose of n-tributyl tetradecyl phosphonium chloride (TPC) and bis(tributyl) tin oxide. The method comprises administering between about 0.1 to about 200 parts of this combined treatment (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.
Type:
Grant
Filed:
August 13, 1990
Date of Patent:
November 5, 1991
Assignee:
Betz Laboratories, Inc.
Inventors:
Deborah K. Donofrio, Wilson K. Whitekettle
Abstract: A bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose of n-tributyl tetradecyl phosphonium chloride (TPC) and (N,N-dimethyl-N'-phenyl-N'-fluorodichloromethylthio) sulphamide ("Preventol A4S"). The method comprises administering between about 0.1 to about 200 parts of this combined treatment (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.
Type:
Grant
Filed:
August 13, 1990
Date of Patent:
November 5, 1991
Assignee:
Betz Laboratories, Inc.
Inventors:
Deborah K. Donofrio, Wilson K. Whitekettle
Abstract: A bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose of glutaraldehyde and dodecylguanidine hydrochloride. The method comprises administering between about 0.1 to about 200 parts of this combined treatment (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.
Abstract: A bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose of glutaraldehyde and bis(trichloromethyl) sulfone. The method comprises administering between about 0.1 to about 200 parts of this combined treatment (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.